Home
Home » companies

InterMune

2 Biotechs To Avoid, 1 To Buy

2 Biotechs To Avoid, 1 To Buy
Motley Fool

Former Intermune CEO Loses Free Speech Appeal

Former Intermune CEO Loses Free Speech Appeal
Pharmalot

InterMune Earnings: Here’s Why Shares are Up Now

InterMune Earnings: Here’s Why Shares are Up Now
Wall St. Cheat Sheet

InterMune Sale Looms as Lung Drug Nears FDA Nod: Real M&A

InterMune Sale Looms as Lung Drug Nears FDA Nod: Real M&A
Bloomberg

Forbes Earnings Preview: InterMune, Inc.

Forbes Earnings Preview: InterMune, Inc.
Forbes

InterMune will sell $85M in debt and 12.5M shares of its stock to fund studies, marketing

InterMune will sell $85M in debt and 12.5M shares of its stock to fund studies, marketing
Yahoo/AP

InterMune says 4Q lung disease drug sales improved

InterMune says 4Q lung disease drug sales improved
Yahoo/AP

Rejection of InterMune’s Drug Told Early to FDA Advisers

Rejection of InterMune’s Drug Told Early to FDA Advisers
Bloomberg

SAC Scrutiny Intensifies as U.S. Probes InterMune Trading

SAC Scrutiny Intensifies as U.S. Probes InterMune Trading
Bloomberg

SAC Capital’s InterMune Trades Said to Be Probed by FBI

SAC Capital’s InterMune Trades Said to Be Probed by FBI
Bloomberg